Skip to main content
Caplight Logo









Saluda Medical

Saluda Medical

Public
Artarmon, New South WalesInformation Technologyhttps://www.saludamedical.com/

Saluda Medical is now publicly traded

The data on this page reflects Saluda Medical's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Dec 5, 2025

Last Round

VC Round

Nov 12, 2025

Total Funding Raised

$684.6M

Company Overview

Saluda Medical is a medical device company that develops and commercializes closed-loop neuromodulation therapies for the treatment of chronic neurological conditions.

Sector

Information Technology

AI Layer

Non-AI

Keywords

spinal cord stimulationSCSclosed-loop stimulationneuromodulationneuromod techclosed-loop neuromodchronic pain managementneurostimulationEvoked Compound Action PotentialsECAPsimplantable medical deviceintractable pain treatmentmedical device hardwarefailed back surgery syndrome

Saluda Medical Comparables

Compare Saluda Medical with similar companies based on industry and business-model similarity.

Saluda Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WISE
59%
Salvia BioElectronics
56%
Reach Neuro, Inc.
51%

Saluda Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPODec 5, 2025
VC RoundNov 12, 2025
VC RoundJan 10, 2025
Series FApr 13, 2023
VC RoundMar 2, 2022
Series E
Jun 28, 2019

Key People

Founding team and executive leadership

Barry Regan

President and CEO Saluda Medical

Executive Team

Jim Erickson

Chief Financial Officer

Executive Team

Saluda Medical Investors

Notable investors and investment history

Saluda Medical investors
InvestorRounds
Redmile GroupIPO, Series F, VC Round, Series E
BioScience ManagersSeries B, Series F
Heartland Healthcare CapitalVC Round
Action Potential Venture CapitalVC Round, Series F, Series D
Fidelity Management & Research CompanyVC Round, IPO, Series F
NSW Medical Device FundGrant
Bell Potter SecuritiesIPO

Recent news

Latest coverage and updates

  • has_revenueAug 6, 2026

    Saluda Medical Pty had revenue of $27M on Jul 29th '26.

Saluda Medical Filings

Explore SEC and related filing metadata, where available.

Saluda Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersArtarmon, New South Wales
Employee Range387
Year Founded2011
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?